Molecular basis for plasma α(1,3)-fucosyltransferase gene deficiency (FUT6)

INSERM U.178, Villejuif, France.
Journal of Biological Chemistry (Impact Factor: 4.57). 05/1994; 269(17):12662-71.
Source: PubMed


While most humans express an alpha(1,3)-fucosyltransferase in plasma, 9% of individuals on the isle of Java (Indonesia) do not express this enzyme. Ninety-five percent of these plasma alpha(1,3)-fucosyltransferase-deficient individuals have Lewis negative phenotype on red cells, suggesting strong linkage disequilibrium between these two traits. To define the molecular basis for this plasma deficiency and to determine which of two candidate human alpha(1,3)-fucosyltransferase genes encode this enzyme (FUT5 and FUT6), we cloned and analyzed alleles at these two loci from an Indonesian individual deficient in plasma alpha(1,3)-fucosyltransferase activity. Single base pair changes were identified in the coding region of each gene, relative to previously published wild type alleles. These changes in turn yield three codon changes in FUT5 and three in FUT6. The codon changes in the FUT5 gene do not yield detectable diminutions in alpha(1,3)-fucosyltransferase activity when tested by expression in transfected COS-1 cells, and none of the FUT5 alleles co-segregate with plasma alpha(1,3)-fucosyltransferase deficiency in Indonesian pedigrees. By contrast, two of the codon changes in the FUT6 alleles inactivate this gene when tested by expression in transfected COS-1 cells. One of these inactivating changes is a missense mutation (Glu-247-->Lys) within the enzyme's catalytic domain. The other inactivating mutation represents a nonsense mutation (Tyr-315-->stop) that truncates the COOH terminus of the enzyme by 45 amino acids. The Glu-247-->Lys missense mutation is present in double dose in the nine plasma alpha(1,3)-fucosyltransferase-deficient individuals tested, whereas the nonsense mutation at tyrosine 315 is present in double dose in just one of these persons. These results demonstrate that the alpha(1,3)-fucosyltransferase activity in human plasma is encoded by the FUT6 gene and that the missense mutation within codon 247 of this gene is responsible for deficiency of this activity in these Indonesian families.

Download full-text

Full-text preview

Available from:
  • Source
    • "The most frequent FUT3 SNPs are the 202T > C, 314C > T, 508G > A and 1067T > A polymorphisms (le genes) which affect and inactivate the catalytic domain of FucT III enzyme (Nishihara et al., 1993, 1994; Kudo et al., 1996), while a further SNP, 59T > G, is known to cause the substitution of an amino acid in the transmembrane region but its effect on enzymatic activity has not yet been defined (Elmgren et al., 1996). The FUT3 202T > C; 314C > T and 59T > G polymorphisms have been reported in all populations in which this gene has been studied (Elmgren et al., 1993, 1996; Mollicone et al., 1994; Nishihara et al., 1994; Kudo et al., 1996; Ørntoft et al., 1996; Liu et al., 1999; Cakir et al., 2002), while the 508G > A and 1067T > A polymorphisms have been identified at a high frequency in Japanese populations (Koda et al., 1993; Nishihara et al., 1994). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Lewis blood group system involves two major antigens, Leª and Leb. Their antigenic determinants are not primary gene products but are synthesized by the transfer of sugar subunits to a precursory chain by a specific enzyme which is the product of the FUT3 gene (Lewis gene). The presence of three FUT3 gene single nucleotide polymorphisms (SNPs) (59T > G; 508G > A and 1067T > A) was related to the Lewis phenotype of erythrocytes from 185 individuals of Japanese ancestry living in the town of Tomé-Açu in the Brazilian Amazon region. This relationship was detected using a serological hemagglutination test and the Dot-ELISA assay along with the molecular technique PCR-RFLP. We found that the three SNPs investigated in this study only accounted for a proportion of the Lewis-negative phenotype of the erythrocytes.
    Genetics and Molecular Biology 03/2007; 30(2). DOI:10.1590/S1415-47572007000300002 · 1.20 Impact Factor
  • Source
    • "The FUT3 and FUT5 enzymes can use both type 1 and type 2 precursors as substrates, FUT3 having a marked preference for type 1 and FUT5 for type 2. The FUT4, FUT6, FUT7 and FUT9 enzymes catalyze addition of a fucose exclusively onto the type 2 precursor [5]. Like the FUT1 and FUT2 genes, polymorphisms have been described for FUT3, FUT5, FUT6 and more recently for FUT7 [6] [7] [8]. Individuals lacking a functional FUT3 allele are called 'Lewis negative' and are characterized by the red cell phenotype Le(a-b-). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Antigens of the ABH and Lewis histo-blood group family have been known for a long time. Yet their biological meaning is still largely obscure. Based on the available knowledge about the genes involved in their biosynthesis and about their tissue distribution in humans and other mammals, we discuss here the selective forces that may maintain or propagate these oligosaccharide antigens. The ABO, alpha 1,2fucosyltransferase and alpha 1,3fucosyltransferase enzyme families have been generated by gene duplications. Members of these families contribute to biosynthesis of the antigens through epistatic interactions. We suggest that the highly polymorphic genes of each family provide intraspecies diversity that allows coping with diverse and rapidly evolving pathogens. In contrast, the genes of low frequency polymorphism are expected to play roles at the cellular level, although they may be dispensable at the individual level. In addition, some members of these three gene families are expected to be functionally redundant and may either provide a reservoir for additional diversity in the future or become inactivated. We also discuss the role of the ABH and Lewis histo-blood group antigens in pathologies such as cancer and cardiovascular diseases, but argue that it is merely incidental and devoid of evolutionary impact.
    Biochimie 08/2001; 83(7):565-73. DOI:10.1016/S0300-9084(01)01321-9 · 2.96 Impact Factor
  • Source
    • "Recently, it has been shown that the activity in serum and plasma is encoded by the FucT VI gene and that missense mutations are responsible for deficiency of this activity in 9% of the population of Java (Mollicone et al., 1994b). A recent study from our laboratory showed that FucT VI, but not FucT TTT or FucT V, is responsible for the fucosylation of glycoproteins in the liver, and that this organ is a major source of the (soluble) FucT activity in plasma (Brinkman-van der Linden et al, 1996). "
    [Show abstract] [Hide abstract]
    ABSTRACT: As an extension of previous study (de Vries et al., 1995, J. Biol. Chem., 270, 8712-8722) the acceptor specificity of recombinant FucT VI, expressed in insect cells as soluble enzyme, and purified from the growth medium by affinity chromatography, was analyzed toward a broad panel of oligosaccharide and glycoprotein substrates. It was found that FucT VI effectively utilizes any type-2-chain based structure (Gal beta 1-->4GlcNAc-R). Neutral as well as sialylated structures are fucosylated with high efficiency. To identify polar groups on acceptors that function in enzyme binding, deoxygenated substrate analogs were tested as acceptors. FucT VI had an absolute requirement for a hydroxyl at C-6 of galactose in addition to the accepting hydroxyl at C-3. Thus, FucT VI, although different from FucT III, IV, and V in acceptor properties, seems to bind the acceptor in a similar way.
    Glycobiology 10/1997; 7(7):921-7. DOI:10.1093/glycob/7.7.921 · 3.15 Impact Factor
Show more